KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
mmu05200
|
Pathways in cancer |
Vegfa,Ccne1,Wnt3a,Ccnd1,Bcl2,Jun, |
5.72E-5 |
mmu04510
|
Focal adhesion |
Vegfa,Ccnd1,Bcl2,Jun, |
2.91E-2 |
mmu04115
|
p53 signaling pathway |
Ccne1,Ccnd1,Mdm4, |
4.85E-2 |
mmu05222
|
Small cell lung cancer |
Ccne1,Ccnd1,Bcl2, |
7.29E-2 |
mmu05210
|
Colorectal cancer |
Ccnd1,Bcl2,Jun, |
7.46E-2 |
|
mmu05215
|
Prostate cancer |
Ccne1,Ccnd1,Bcl2, |
8.15E-2 |
mmu04310
|
Wnt signaling pathway |
Wnt3a,Ccnd1,Jun, |
2.13E-1 |
mmu05219
|
Bladder cancer |
Vegfa,Ccnd1, |
6.40E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0008283
|
cell proliferation |
Bcl2l2,Vegfa,Wnt3a,Ccnd1,Bcl2,Mdm4, |
1.36E-6 |
GO:0051726
|
regulation of cell cycle |
Ccne1,Ccnd1,Bcl2,App,Jun, |
2.68E-5 |
GO:0007049
|
cell cycle |
Ccne1,Ccnd1,Bcl2,App,Arl2,Mdm4, |
1.10E-4 |
GO:0030182
|
neuron differentiation |
Vegfa,Wnt3a,Jag1,Bcl2,App, |
3.00E-4 |
GO:0006915
|
apoptosis |
Bcl2l2,Bcl2,App,Cadm1,Mdm4, |
5.38E-4 |
|
GO:0012501
|
programmed cell death |
Bcl2l2,Bcl2,App,Cadm1,Mdm4, |
5.74E-4 |
GO:0048732
|
gland development |
Vegfa,Wnt3a,Ccnd1,Bcl2, |
5.99E-4 |
GO:0008219
|
cell death |
Bcl2l2,Bcl2,App,Cadm1,Mdm4, |
7.46E-4 |
GO:0016265
|
death |
Bcl2l2,Bcl2,App,Cadm1,Mdm4, |
8.15E-4 |
GO:0051329
|
interphase of mitotic cell cycle |
Ccnd1,Bcl2,App, |
8.21E-4 |
GO:0051325
|
interphase |
Ccnd1,Bcl2,App, |
8.89E-4 |
GO:0007423
|
sensory organ development |
Vegfa,Wnt3a,Jag1,Bcl2, |
1.29E-2 |
GO:0060429
|
epithelium development |
Vegfa,Jag1,Bcl2,Jun, |
1.51E-2 |
GO:0048666
|
neuron development |
Vegfa,Wnt3a,Bcl2,App, |
1.87E-2 |
GO:0030879
|
mammary gland development |
Vegfa,Wnt3a,Ccnd1, |
2.50E-2 |
GO:0008406
|
gonad development |
Bcl2l2,Vegfa,Bcl2, |
2.62E-2 |
GO:0007346
|
regulation of mitotic cell cycle |
Ccnd1,Bcl2,App, |
3.11E-2 |
GO:0000320
|
re-entry into mitotic cell cycle |
Ccnd1,Mdm4, |
3.52E-2 |
GO:0045137
|
development of primary sexual characteristics |
Bcl2l2,Vegfa,Bcl2, |
3.64E-2 |
GO:0043583
|
ear development |
Wnt3a,Jag1,Bcl2, |
3.64E-2 |
GO:0022402
|
cell cycle process |
Ccnd1,Bcl2,App,Mdm4, |
4.34E-2 |
GO:0032504
|
multicellular organism reproduction |
Vegfa,Ccnd1,Bcl2,Cadm1, |
4.86E-2 |
GO:0048609
|
reproductive process in a multicellular organism |
Vegfa,Ccnd1,Bcl2,Cadm1, |
4.86E-2 |
GO:0032469
|
endoplasmic reticulum calcium ion homeostasis |
Bcl2,App, |
5.28E-2 |
GO:0048608
|
reproductive structure development |
Bcl2l2,Vegfa,Bcl2, |
5.63E-2 |
GO:0007548
|
sex differentiation |
Bcl2l2,Vegfa,Bcl2, |
5.63E-2 |
GO:0032845
|
negative regulation of homeostatic process |
Vegfa,Bcl2, |
6.16E-2 |
GO:0006378
|
mRNA polyadenylation |
Bcl2l2,App, |
7.04E-2 |
GO:0010608
|
posttranscriptional regulation of gene expression |
Vegfa,Bcl2,App, |
7.23E-2 |
GO:0007409
|
axonogenesis |
Wnt3a,Bcl2,App, |
8.72E-2 |
GO:0035239
|
tube morphogenesis |
Vegfa,Wnt3a,Bcl2, |
9.56E-2 |
GO:0043631
|
RNA polyadenylation |
Bcl2l2,App, |
9.67E-2 |
|
|
|
|
|
|